1. A case of type 1 segmental Darier disease showing widespread Blaschkoid skin lesions with p.P160L mutation in ATP2A2. (8th June 2020) Authors: Agematsu, A.; Kamata, M.; Uchida, H.; Nagata, M.; Fukaya, S.; Hayashi, K.; Fukuyasu, A.; Tanaka, T.; Ishikawa, T.; Ohnishi, T.; Tada, Y.; Kubo, A. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 10(2020) Page Start: e633 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Ciclosporin A inhibits production of interleukin‐12/23p40 and interleukin‐23 by the human monocyte cell line, THP‐1. (18th June 2013) Authors: Kamata, M.; Tada, Y.; Tatsuta, A.; Kawashima, T.; Shibata, S.; Mitsui, H.; Asano, Y.; Sugaya, M.; Kadono, T.; Kanda, N.; Watanabe, S.; Sato, S. Journal: Clinical and experimental dermatology Issue: Volume 38:Number 5(2013) Page Start: 545 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Morphological change in peristaltic crawling motion of a narrow pipe inspection robot inspired by earthworm's locomotion. (3rd April 2018) Authors: Kamata, M.; Yamazaki, S.; Tanise, Y.; Yamada, Y.; Nakamura, T. Journal: Advanced robotics Issue: Volume 32:Number 7(2018) Page Start: 386 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Real‐world effectiveness and safety of dupilumab for the treatment of atopic dermatitis in Japanese patients: a single‐centre retrospective study. (1st November 2019) Authors: Uchida, H.; Kamata, M.; Mizukawa, I.; Watanabe, A.; Agematsu, A.; Nagata, M.; Fukaya, S.; Hayashi, K.; Fukuyasu, A.; Tanaka, T.; Ishikawa, T.; Ohnishi, T.; Tada, Y. Journal: British journal of dermatology Issue: Volume 181:Number 5(2019) Page Start: 1083 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Real‐world effectiveness and safety of dupilumab for the treatment of atopic dermatitis in Japanese patients: a single‐centre retrospective study. (22nd August 2019) Authors: Uchida, H.; Kamata, M.; Mizukawa, I.; Watanabe, A.; Agematsu, A.; Nagata, M.; Fukaya, S.; Hayashi, K.; Fukuyasu, A.; Tanaka, T.; Ishikawa, T.; Ohnishi, T.; Tada, Y. Journal: British journal of dermatology Issue: Volume 181:Number 5(2019) Page Start: 1083 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Secukinumab decreases serum Krebs von den Lungen 6 (KL‐6) level in patients with psoriasis with elevated serum KL‐6 level. (1st December 2018) Authors: Chijiwa, C.; Takeoka, S.; Kamata, M.; Uchida, H.; Fukaya, S.; Hayashi, K.; Fukuyasu, A.; Tanaka, T.; Ishikawa, T.; Ohnishi, T.; Tada, Y. Journal: British journal of dermatology Issue: Volume 179:Number 6(2018) Page Start: 1396 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Secukinumab decreases serum Krebs von den Lungen 6 (KL‐6) level in patients with psoriasis with elevated serum KL‐6 level. (23rd September 2018) Authors: Chijiwa, C.; Takeoka, S.; Kamata, M.; Uchida, H.; Fukaya, S.; Hayashi, K.; Fukuyasu, A.; Tanaka, T.; Ishikawa, T.; Ohnishi, T.; Tada, Y. Journal: British journal of dermatology Issue: Volume 179:Number 6(2018) Page Start: 1396 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Serum IL‐33 levels are increased in patients with psoriasis. (15th May 2015) Authors: Mitsui, A.; Tada, Y.; Takahashi, T.; Shibata, S.; Kamata, M.; Miyagaki, T.; Fujita, H.; Sugaya, M.; Kadono, T.; Sato, S.; Asano, Y. Journal: Clinical and experimental dermatology Issue: Volume 41:Number 2(2016) Page Start: 183 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Serum IL‐33 levels are increased in patients with psoriasis. (1st March 2016) Authors: Mitsui, A.; Tada, Y.; Takahashi, T.; Shibata, S.; Kamata, M.; Miyagaki, T.; Fujita, H.; Sugaya, M.; Kadono, T.; Sato, S.; Asano, Y. Journal: Clinical and experimental dermatology Issue: Volume 41:Number 2(2016) Page Start: 183 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Serum soluble CD26 levels: diagnostic efficiency for atopic dermatitis, cutaneous T‐cell lymphoma and psoriasis in combination with serum thymus and activation‐regulated chemokine levels. (14th November 2011) Authors: Miyagaki, T.; Sugaya, M.; Suga, H.; Morimura, S.; Kamata, M.; Ohmatsu, H.; Fujita, H.; Asano, Y.; Tada, Y.; Kadono, T.; Sato, S. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 27:Number 1(2013:Jan.) Page Start: 19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗